BMH Medical Journal 2015;2(3):79-83   Case Report

Cryptogenic Organising Pneumonia  As The Initial Presenting Manifestation of SLE

Neena Mampilly MD,  G Manoj MD, Binoy J Paul MD, PhD, DNB, FRCP

Baby Memorial Hospital, Kozhikode, Kerala, India. PIN: 673004

Address for Correspondence:  Dr. Neena Mampilly MD, Senior Consultant Pathologist, Baby Memorial Hospital, Kozhikode, Kerala, India. PIN: 673004.  E-mail: neenamampilly@gmail.com

Abstract:

Cryptogenic Organising Pneumonia (COP), also called idiopathic Bronchiolitis Obliterans Organising Pneumonia( BOOP), is a  distinct entity  among the idiopathic interstitial pneumonias defined histopathologically by intraalveolar buds of granulation tissue. The etiology includes idiopathic, infectious, drug induced radiation induced and  connective tissue diseases. Organising pneumonia occurs particularly in patients with dermatomyositis-polymyositis where it may be the presenting  manifestation, and rarely in SLE, rheumatoid arthritis, scleroderma and other connective tissue diseases.  We describe  a 30 yr old  lady  who initially presented with respiratory symptoms, not responding to antibiotics. She was subsequently  diagnosed as  SLE and  HRCT thorax showed consolidation involving both lung fields. A  percutaneous   lung biopsy revealed features of Cryptogenic Organising Pneumonia.

Keywords: Cryptogenic Organising Pneumonia, Bronchiolitis Obliterans Organising Pneumonia, SLE

Case report

A 30-year old female  was admitted in a local hospital with fever, right sided chest pain, cough and breathlessness of 5 days duration. Physical examination and chest X-ray (Figure 1) was suggestive of right lobar pneumonia and she  was  put on  Coamoxyclav. In spite of antibiotics, fever was persisting and lung signs extended to left side. Repeat X-ray chest showed nonhomogenous opacity extending to the lower zones of both lung (Figure 2).



Figure 1: X ray chest suggestive of right lower lobe consolidation




Figure 2: Repeat  X ray chest  showing consolidation extending to left lower zone

Hence ceftriaxone was also added to coamoxyclav. However fever was persisting  and patient developed erythematous facial rash suggestive of malar rash of systemic lupus erythematosus (SLE). ANA (IIF) and antidsDNA done were found to be positive. Meanwhile the patient started developing dyspnoea and tachycardia and  was referred to our centre. ECG taken was suggestive of atrial flutter. Echocardiography done showed global left ventricular dysfunction, normal valves, no vegetations.  D-dimer test was negative. Patient was diagnosed as myocarditis  secondary to SLE and put on ACE inhibitor and diuretics. Anticardiolipin antibody (IgG, IgM) and lupus anticoagulants were negative. Renal and liver function tests and  urine examination were normal.

Next day patient developed dimness of vision and optic fundus examination showed retinal vasculitic changes with haemorrhages. Patient was started  on pulse methyl prednisolone (1gm IV x 3 days) followed by oral prednisolone 40mg/day along with hydroxychloroquine and azathioprine. 3 days later she became restless with violent behavior. Physical examination didn't reveal any neck stiffness or focal neurological deficits. Repeat RFT, serum electrolytes and MRI brain were normal. Patient improved with antipsychotics. Her pulmonary findings were not improving clinically. An HRCT Thorax  showed segmental consolidation in the right middle lobe and both lower lobes. (Figure 3)



Figure 3: CT scan showing subpleural consolidation in posterior and lateral segments of right middle lobe, lateral basal segment of right lower lobe, superior and posterobasal segement of both lower lobes.

The differential diagnosis of CT Findings were lupus pneumonitis, infections, alveolar haemorrhage or organizing pneumonia. As the patient was not willing for bronchoscopy with bronchial lavage, a transthoracic lung biopsy was done. The biopsy showed alveolar air spaces filled with proliferating fibroblasts and polypoidal intraluminal fibrocollagenous plugs (Masson bodies) suggestive of Cryptogenic  Organizing Pneumonia (COP). (Figure 4

 

Figure 4: Lung biopsy showing alveolar airspaces filled with proliferating fibroblasts and polypoid intraluminal firbrocollagenous plugs (Masson bodies)

Patient was continued on oral prednisolone (1mg/kg/day) Hydroxy chloroquine and  Azathioprine were also continued. Patient showed a slow but steady improvement. An X ray chest taken after 4 weeks showed marked clearance of the lung shadows (Figure 5)
 


Figure 5:  Xray chest one month after starting  steroids showing marked clearance of lung shadows

Discussion

Cryptogenic Organising Pneumonia (COP) is classified as a distinct entity among the idiopathic interstitial pneumonias [1]. The mean age of onset is 50-60 yrs, not related to smoking. Clinically presents with fever, cough, malaise and dyspnea. Since the manifestations are nonspecific, diagnosis is often delayed. HRCT scans can be used to aid diagnosis. The main imaging patterns include multiple alveolar opacities (typical COP), solitary opacity (focal COP), and infiltrative opacities (infiltrative COP) [2].

Definitive diagnosis of COP  requires a lung biopsy. The hallmark of organizing pneumonia is the presence of intraalveolar buds of granulation tissue consisting of fibroblasts-myofibroblasts embedded in connective tissue. These buds may extend from one alveolus to the next through the interalveolar pores and into the bronchioles obstructing the lumen (bronchiolitis obliterans). The pathogenesis involves alveolar epithelial injury as the initiating event, with necrosis and sloughing of pneumocytes resulting in the denudation of the epithelial basal laminae, intraalveolar fibrinoid inflammatory cell clusters, colonization by fibroblasts and finally the formation of mature fibrotic buds, sharing many similarities with the process of cutaneous wound healing [3,4]. The etiology of COP  includes infections (pneumococcal pneumonia,bacteria, viruses, parasites and fungi), iatrogenic (drug induced or radiation induced), connective tissue diseases, organ transplant, hematological malignancies, and inflammatory bowel disease.

Among the connective tissue diseases, Cryptogenic Organising Pneumonia occurs particularly in patients with dermatomyositis-polymyositis where it may be the presenting manifestation [5]. It has also been reported in rheumatoid arthritis, scleroderma, CREST syndrome and Sjogren syndrome.

Cryptogenic Organising pneumonia is rarely an initial presenting manifestation of  Systemic Lupus Erythematosus [SLE], and there are only few case reports in the literature [6-9]. The pulmonary manifestations of SLE are varied and include acute lupus pneumonitis, diaphragmatic dysfunction and shrinking lung syndrome, cavitating pulmonary nodules, pulmonary hypertension, pulmonary vasculits, pulmonary embolism, alveolar hemorrhage, chronic interstitial pneumonitis, opportunistic pulmonary infections, drug toxicity from immunosuppressive therapy and bronchiolitis obliterans (with or without organizing pneumonia) [10]. Hence the importance of a tissue diagnosis  cannot be overemphasized.

Corticosteroid treatment results in slow but steady clinical improvement and clearing of the opacities on chest imaging without significant sequelae, as in our case. However relapses are common upon stopping or reduction of steroids, thus often requiring prolonged treatment.

Conclusions

Cryptogenic Organising Pneumonia as the initial manifestation of SLE is rare and requires a high degree of clinical suspicion, along with HRCT imaging and a tissue diagnosis. 

References

1. Cordier JF. Cryptogenic organizing pneumonia. Eur Respir J 2006;28;422-446.

2. Cordier JF,Loire R,Brune J;Idiopathic Bronchiolitis Obliterans Organising Pneumonia.Definition of characteristic clinical profiles in a series of 16 patients; Chest; 1989; 96; 999-1004.

3. Cordier JF. The concept of organizing pneumonia. In; Desmouliere A, Tuchweber B, eds. Tissue Repair and Fibrosis. The role of the Myofibroblast. Berlin, Springer, 1999; pp. 149-156.

4. Singer AJ, Clark RA. Cutaneous wound healing. N Eng J Med 1999; 341; 738-746.

5. Fata F, Rathore R, Schiff C, Herzlich BC. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis; South Med J 1997; 90; 227-230.

6. Min JK, Hong YS, Park SH, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol 1997; 24; 2254-2257.

7. Otsuka F, Amano T, Hashimoto N, et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody; Intern Med ;1996; 35; 341-344.

8. Gammon RB, Bridges TA, al-Nezir H, Alexander CB, Kennedy JI. Bronchiolitis obliterans organizing pneumonia associated with Systemic Lupus Erythematosus, Chest; 1992; 102; 1171-1174.

9. Dhanya T S, Rajagopal T P, Ravindran C, Binoy J Paul; Bronchiolitis Obliterans Organising Pneumonia in SLE; An unusual presentation; Pulmon 2006; 7 ;2; 81-84.

10. Michael P Keane, Joseph P Lynch III; Pleuropulmonary manifestations of systemic lupus erythematosus; Thorax 2000;55 ; 159-166.